New York City hospitals drop Palantir as controversial AI firm expands in UK
theguardian.com
March 26, 2026
6 min read
🔥🔥🔥🔥🔥
62/100
Summary
New York City's public hospital system will not renew its contract with Palantir, which is set to expire in October. The contract primarily focused on recovering funds for insurance claims amid growing controversy over Palantir's government contracts in the UK.
Key Takeaways
- New York City's public hospital system will not renew its contract with Palantir, which is set to expire in October 2026, after paying nearly $4 million since November 2023.
- Palantir's technology was used for revenue cycle optimization, but NYC Health + Hospitals will transition to in-house systems with no data shared with Palantir post-contract.
- Palantir faces scrutiny in the UK over privacy issues related to its £330 million contract with the National Health Service, with concerns that it may enable state abuses of power.
- The Financial Conduct Authority in the UK awarded Palantir a contract to investigate financial crime, prompting calls from some lawmakers for a government investigation into the agreement.
Community Sentiment
Concerns
- Allowing Palantir access to private medical data raises significant ethical concerns, highlighting the risks associated with data privacy in healthcare.
- The perception of Palantir as a 'spyware firm' suggests a lack of trust in their AI capabilities and intentions, which could hinder their acceptance in sensitive sectors.
- Concerns about Palantir's involvement in government contracts reflect broader anxieties about the implications of surveillance technology in public safety and privacy.
